AbstractThe greatest potential environmental benefit of metabolic engineering would be the production of high-volume commodity chemicals, such as biofuels. Yet, the high yields required for the economic viability of low-value chemicals is particularly hard to achieve in microbes owing to the myriad competing biochemical pathways. An alternative approach, which we call synthetic biochemistry, is to eliminate the organism by constructing biochemical pathways in vitro. Viable synthetic biochemistry, however, will require simple methods to replace the cellular circuitry that maintains cofactor balance. Here we design a simple purge valve module for maintaining NADP+/NADPH balance. We test the purge valve in the production of polyhydroxybutyryl bioplastic and isoprene鈥攑athways where cofactor generation and utilization are unbalanced. We find that the regulatory system is highly robust to variations in cofactor levels and readily transportable. The molecular purge valve provides a step towards developing continuously operating, sustainable synthetic biochemistry systems. IntroductionMetabolic engineering and synthetic biology have been employed for the production of high-value chemicals but has not been as successful in meeting the stringent economics of large-scale commodity chemical manufacturing1. Microbial systems are often hampered by a variety of technical challenges that make it hard to achieve cost competitiveness, including poor yields owing to competing pathways; low productivity caused by slow growth rates or difficulties in pathway optimization; contaminating microbial growth; product toxicity; and expensive product isolation2,3.Another approach that is beginning to receive attention is to perform complex biochemical transformations using mixtures of enzymes in a reaction vessel rather than within a cell. Building single, dedicated pathways in vitro can eliminate side reactions that occur in the cell, so that nearly 100% yields and fast reaction times are possible3,4,5. In vitro biochemical systems also allow for more precise control over optimization and product toxicity problems can be more easily diagnosed and mitigated6,7. Moreover, product extraction can be more facile.Traditionally, in vitro pathway construction has been relegated to use as a research tool or in applications that require only 1鈥? enzymes for the production of chiral compounds and other high-value chemicals1,8,9. Improvements in protein expression and access to stable enzymes have made more complex systems possible, however1,9,10,11,12. In vitro biotransformation systems have been reported in recent years involving systems of over 30 enzymes13,14. One of the first modern studies in this area was an artificial pathway that produced hydrogen from starch1,15,16,17. The concept was recently advanced with a creative system that generated hydrogen from cellobiose at nearly 100% yields16. In another effort, hyper-thermophilic glycolysis enzymes were heterologously expressed, heat purified and assembled to convert glucose to n-butanol in 82% yield18. In another study, an elegantly simplified non-phosphorylative Entner鈥揇oudoroff pathway from hyper-thermophilic archaea was constructed to produce ethanol and isobutanol in ~55% yields19. These pioneering studies illustrate the flexibility of synthetic biochemistry and the potential for high yields.A limiting feature of earlier work in synthetic biochemistry systems is the need to either feed the systems with high-energy cofactors, or if they are generated by the pathway in situ, balance their use to ensure regeneration. For example, in the Sieber pathway to generate ethanol and isopropanol from glucose19, the pathway was beautifully designed to reduce only 2鈥塵ol of NAD+ to NADH during the catabolic phase and to reoxidize 2鈥塵ol of NADH in the anabolic phase. Thus, the utilization of NAD+ was perfectly balanced allowing multiple passes through the pathway. In other systems, the pathways were also designed to maintain cofactor balance18.The requirement for perfect balance limits synthetic biochemistry in two ways, however. First, it places stringent constraints on pathway design, potentially limiting the types of chemicals that can be made. Second, it may ultimately limit the number of cycles the system can perform without adding additional, expensive high-energy cofactors. Why? If there is any spontaneous oxidation of NADH, it effectively creates an unintended cofactor imbalance because more NADH is required than would be expected based on the stoichiometry of the system. Thus, over time the levels of NADH will dissipate and the system will wind down. As the economic viability of a synthetic biochemistry system will likely depend on the ability to run the systems in a self-sustaining manner for long periods of time, we need to develop methods that can maintain high-energy cofactor levels without requiring perfect pathway stoichiometry.Ideally, we believe that a synthetic biochemistry system should be able to generate more high-energy cofactors in the catabolic phase of the pathway, than is needed in the anabolic phase of the pathway so that gradual losses by spontaneous ATP hydrolysis or NAD(P)H oxidation can be tolerated. On the other hand, if an excess of high-energy cofactors is produced, it is necessary to also find a way to dissipate excess production so that the reactions can proceed (that is, carbon flux can be maintained). In short, we need a way to maintain cofactor balance. If it were possible to regulate cofactor balance without affecting carbon flux, it would also allow for much more flexibility in pathway design. As a step towards this goal, we describe a synthetic biochemistry purge valve module to maintain the proper balance of NADPH and test whether this general approach can be applied for the production of the bioplastic polyhydroxybutyrate (PHB) and isoprene.PHB and other polyhydroxyalkanoates (PHAs) are biodegradable thermoplastics. PHAs can have characteristics similar to many popular petrochemical-derived polymers, but are nontoxic and biodegradable, so they are attracting increased attention as a possible green alternative to petroleum-based polymers in a wide range of applications20,21,22. The best characterized and most abundant PHA polymer is PHB that is naturally produced from acetyl-CoA as a carbon and energy storage mechanism in many organisms22. Currently, industrial production of PHB is done by in vivo batch culture processes under nutrient starvation. This process is typically very time consuming, requires large fermentation volumes and requires expensive methods for the extraction of PHB20. Prior attempts to produce bioplastic in vitro have required the addition of sacrificial substrates and a molar excess of cofactors to convert acetate to PHB23.Isoprene is a platform chemical for a variety of products, but it is mostly employed in the production of synthetic rubber24,25,26. The isoprenoid pathway also provides precursors for over 25,000 known biomolecules including drugs such as taxol and potential biofuels27. There have been a number of efforts to produce isoprene in microorganisms24,26,28,29 and the best reported yield is 28% from glucose24. We recently showed that a synthetic biochemistry system could produce isoprene in 95% yield from pyruvate as long as high-energy cofactors were added30.Here we employ a purge valve system in a pathway to convert pyruvate into PHB that maintains sustainable reducing cofactor balance, without the requirement for perfect stoichiometric matching of cofactor generation and carbon usage. Further, we show that our purge valve module can be used as the basis for the production of other acetyl-CoA-derived products by applying it to the production of isoprene from pyruvate via the mevalonate pathway. Regulatory modules such as this can free us from having to perfectly balance cofactor utilization when designing synthetic biochemistry systems.ResultsOverview and design of pathwayThe biotransformation of pyruvate into PHB illustrates a basic cofactor imbalance problem that is encountered in biochemical systems. In particular, conversion of pyruvate to acetyl-CoA by pyruvate dehydrogenase (PDH) yields one molecule of NADH. However, the three-enzyme pathway (phaA, B and C) to PHB from acetyl-CoA utilizes only one half of a molecule of NADPH per acetyl-CoA. Thus, the canonical pathway produces an excess of reducing equivalents. Moreover, the reducing equivalents are of the wrong type (NADH rather than NADPH). We therefore designed a pathway, shown in Fig. 1a that can generate the correct cofactor and regulate its production.Figure 1: A synthetic biochemistry purge valve system for the production of PHB.(a) The in vitro metabolic pathway for the conversion of pyruvate to PHB. The pathway consists of six separate reactions: reaction 1 (PDHNADH), reaction 1鈥?(PDHNADPH), reaction 2 (NoxE), reaction 3 (PhaA), reaction 4 (PhaB) and reaction 5 (PhaC). The purge valve is highlighted in the red box. (b) How the purge valve is designed to function. At low NADPH (high NADP+), PDHNADPH reaction dominates, generating acetyl-CoA and NADPH from pyruvate and NADP+. The purge valve is effectively 鈥榦ff鈥? In high-NADPH (low NADP+) conditions, the PHDNADPH enzyme is starved for oxidized cofactor, shutting down this pathway to acetyl-CoA. In this situation, the PDHNADH/NoxE system takes over, producing only acetyl-CoA. In other words, the purge valve is effectively 鈥榦n鈥? (c) A chemical engineering schematic of the purge valve system used in the production of PHB from pyruvate, involving a cofactor recycle loop.Full size imageIn our design, we create a synthetic biochemistry 鈥榩urge valve鈥?that effectively decouples the stoichometric production of NAD(P)H from acetyl-CoA (Fig. 1). To this end, we employ a mixture of both an NAD+-utilizing wild-type (WT) PDH (PDHNADH), a mutant PDH that utilizes NADP+ (PDHNADPH), and a water-generating NADH oxidase (NoxE) that specifically oxidizes NADH, but not NADPH31,32. By employing this metabolic node, we generate NADPH needed for PHB production from pyruvate, but also dissipate excess reducing equivalents in an autoregulatory manner. As illustrated in Fig. 1b, under low-NADPH, high-NADP+ conditions, the mutant PDHNADPH can operate to generate acetyl-CoA and restore NADPH levels. Under high-NADPH, low-NADP+ conditions, the PDHNADPH activity will automatically be choked off, and the WT PDHNADH will be used preferentially to produce acetyl-CoA and NADH. In this high-NADPH condition, the reducing equivalents are not needed. Because the reducing equivalents are produced in the form of NADH and not NADPH, they are eliminated by the oxidase, NoxE. The presence of NoxE ensures that NADH never builds up and the PDHNADH can always operate to generate carbon for the PHB pathway in the form of acetyl-CoA. The PDHNADH/PDHNADPH/NoxE system acts like a purge valve that opens under conditions of high NADPH to relieve the excess reducing equivalent 鈥榩ressure鈥?(that is, buildup of NADH) and allow carbon flux to be maintained. An engineering schematic of the purge valve system is shown in Fig. 1c.Enzyme engineering and cofactor specificityTo implement our purge valve module, we needed an NADP+-utilizing PDH. A mutant of Escherichia coli PDH has been engineered to have NADP+ specificity by introducing mutations into the E3 enzyme (EcE3)33. The E. coli PDH proved too unstable for our system, however. We therefore engineered a mutant of the thermophilic Geobacillus stearothermophilus PDH that preferentially accepts NADP+ with increased enzyme stability.Similar to the design of the E. coli PDH mutant, the G. stearothermophilus PDH mutant was designed by overlaying the known structure of the G. stearothermophilus E3 subunit (GsE3)33 with the known structure of the related E. coli glutathione reductase, which utilizes NADP+ (ref. 33) (REF or PDBID:1GET). The structural superposition allowed us to position the additional phosphate moiety in the active site of the GsE3, based on how it was placed in glutathione reductase (see Fig. 2). We could then design side-chain substitutions in GsE3 that might allow acceptance of the phosphate. We were guided by the prior successful design of the EcE3 enzyme, which shares 47% sequence identity with the GsE3 (refs 33, 34). The mutations introduced into EcE3 were E206V, G207R, A208K, G209H and S213R (GsE3 numbering). After examining the changes in the context of the GsE3 structure, we decided to introduce all but G209H, because it appeared that the new His side chain might create steric clashes with nearby K224 and N237 residues.Figure 2: Design of the PDHNADPH enzyme.The structures of the wild-type G. stearothermophilus E3 subunit (E3, green backbone trace) is shown overlaid on the structure of E. coli glutathione reductase (GTX-NADPH, grey backbone trace). The NADPH substrate from glutathione reductase is shown in stick representation, showing the placement of the phosphate moiety that needs to be accommodated. The residues changed to accept the phosphate (E206V, G207R, A208K and S213R) are shown in purple.Full size imageThe kinetic properties of the engineered and WT enzymes reveal that the mutations alter specificity as desired. The kinetic parameters are listed in Supplementary Table 1. For the WT G. stearothermophilus enzyme (GsPDHNADH), kcat is 11.2 times higher with NAD+ than NADP+ and kcat/Km is 1,150 times higher. For the engineered mutant (GsPDHNADPH), kcat is 7.3 times higher with NADP+ than NAD+ and kcat/Km is 21 times higher. Thus, we were able to flip the specificity of the PDH enzyme.The GsPDHNADH and GsPDHNADPH enzymes (henceforth designated PDHNADH and PDHNADPH) were much more stable than their E. coli counterparts. As shown in Supplementary Fig. 1, the G stearothermophilus enzymes retained ~50% activity after 1鈥塰 incubation at 67鈥壜癈, whereas the E. coli PDH enzymes were completely inactivated at 50鈥壜癈.A second key requirement of the purge valve design is the use of an NADH oxidase with high cofactor specificity. We chose NoxE from Lactococcus lactis as it is a water-forming NADH oxidase so it does not generate any toxic products such as hydrogen peroxide31,32,35. As shown in Table 1, the Kcat of NoxE is 248.8 times greater with NADH than NADPH and kcat/Km is 9,900 times greater.Table 1 Enzymes used in this work.Full size tableEnzyme catalysed production of PHB from pyruvateThe enzymes chosen for use in this work are listed in Table 1. In the initial tests, we only employed the WT, PDHNADH complex and NoxE to generate acetyl-CoA and supplied NADPH exogenously. After optimizing enzyme ratios in this simple system, we then added the mutant PDHNADPH to test in situ generation of NADPH. Finally, the amount of PDHNADPH was optimized, keeping the other enzymes fixed.The progress of the optimized pyruvate to PHB reaction is shown in Fig. 3 along with a control lacking the last enzyme, phaC. Both reactions had a PDHNADPH:PDHNADH ratio of 40:1. At this ratio, the NADPH levels rise rapidly (A340) and are maintained throughout the time course (NoxE rapidly oxidizes NADH so changes in A340 reflect only changes in NADPH levels). At the same time, PHB granules are produced as monitored by A600 (ref. 36).Figure 3: Production of PHB using an optimized system.In this reaction, the production of PHB is monitored by an increase A600 (blue) caused by precipitation of the PHB granules. No increase is seen in the absence of the PHB polymerase, PhaC. The production of PHB is confirmed by a gas chromatography assay (see text). The A340 (red) monitors the level of NADPH because no NADH is allowed to build up because of the presence of NoxE. The purge valve system maintains a high level of NADPH throughout the reaction.Full size imageWe assayed the PHB production using a gas chromatography method and found that the optimized reaction produced 2.45卤0.5鈥塵g鈥塵l鈭? of PHB from 50鈥塵M pyruvate, which represents nearly complete conversion (94卤20%) of pyruvate to plastic. In the optimized system, we started with 0.5鈥塵M NADP+, so achieving 94% yield requires over 90 turnovers of the NADP+ cofactor, indicating a high level of system sustainability.The stability of the full system was assessed by mixing components together and then initiating the reaction at various time delays. The decrease in extent of the reaction is shown in Supplementary Fig. 2. We find that the extent of reaction remains ~50% after 2 days.Autoregulatory behaviour of purge valveThe regulatory behaviour of the purge valve is better seen at sub-optimal enzyme concentrations and ratios of PDHNADPH to PDHNADH that slow down the response time. In the optimized assay (40:1鈥塵ol ratio of PDHNADPH:PDHNADH), we observed a rapid rise in NADPH levels, which was sustained throughout. In the non-optimal systems shown in Fig. 4, the purge valve cannot respond as rapidly to drops in NADPH concentrations so we can observe variations in NADPH levels as the system develops. We still observe a rapid initial rise in NADPH levels, but as intermediates build up, the consumption starts to outstrip NADPH production. Eventually, the system compensates by generating higher levels of NADPH. The restoration of NADPH levels would be impossible without the proper operation of the purge valve system.Figure 4: Time course of pyruvate to PHB optimization reaction using sub-optimal ratios of PDHNADPH and PDHNADH.The A340 traces (red), monitoring NADPH levels fall into three distinct phases. A fast initial reduction of NADPH by the PDHNADPH is followed by a slow oxidation of NADPH by PhaB as the intermediate levels rise. As the reaction proceeds, the purge valve effectively turns off and NADPH levels rise again. The evolution of the system coincides with the increase at A600 (blue), which represents the precipitation of the PHB granules from solution.Full size imageThe system is robust to cofactor levelsTo test whether the system was robust to changes in cofactor levels, we varied the initial cofactor concentrations in the reactions and measured the yields of PHB. Each reaction was constructed with combinations of NAD+, NADH, NADP+ or NADPH at either 0.1 or 1鈥塵M and the production of PHB was monitored by the final OD at 600鈥塶m. All of the reaction conditions were compared with the optimized reaction that produced nearly complete conversion of pyruvate to PHB and, as shown in Fig. 5, were within random variation (see also Supplementary Table 3). This result indicates that the purge valve can compensate readily for changes in cofactor concentrations and reduction states.Figure 5: The purge valve system is robust.The graph shows relative yield of PHB upon starting with different amounts of each of the cofactors. The relative yields represent the ratio of the final A600 for the reaction, relative to the final A600 for the optimized reaction. All reactions show a relatively robust yield in comparison with the negative control lacking the final phaC enzyme (orange bar). The error bars reflect the s.d. of three independent reactions. The data are listed in Supplementary Table 3.Full size imagePorting the purge valve system to isoprene productionTo test the versatility of the molecular purge valve and whether it can be applied as a general platform for the production of a diverse array of acetyl-CoA-derived compounds, we used the PDH purge valve to produce isoprene via the acetyl-CoA-dependent mevalonate pathway. We have previously described the in vitro production of isoprene from pyruvate, which required the use of exogenously added NADPH30. Similar to the PHB pathway, the mevalonate pathway has an inherently different carbon and cofactor stoichiometry. In particular, the mevalonate pathway requires three acetyl-CoA and two NADPH for the production of isoprene (see Fig. 6a). Thus, system sustainability requires generation and regulation of NADPH levels.Figure 6: Employing the purge valve for the production of isoprene.(a) The in vitro metabolic pathway for the conversion of pyruvate to isoprene. The purge valve highlighted in the red box consists of the same enzymes/reactions as in Fig. 1. In the mevalonate pathway, three acetyl-CoA are used to make HMG-CoA (enzymes 6 and 7). HMG-CoA is reduced by HMGR (enzyme 8) with two NADPH to give mevalonate. Three ATP are then used to convert mevalonate to isopentenyl pyrophosphate followed by production of isoprene (enzymes 9鈥?3). (b) The graph shows the dependence of isoprene production on the purge valve. No purge valve was used in the first reaction (PDHNADH, NADPH and NoxE). NADPH was simply added and NADH recycled using NoxE. The final experiment (PDHNADH, PDHNADPH and NoxE) shows results employing the full purge valve system. Leaving out any component of the purge valve system resulted in marked decreases in isoprene production. Each reaction was performed in duplicate and the error was calculated as the s.d. of the two replicates.Full size imageWe tested whether the purge valve system can replace exogenously added NADPH in the production of isoprene. As shown in Fig. 6b, the full purge valve system produces an 88.2卤8.4% yield from 3鈥塵M pyruvate. This yield is even higher than the 81.4卤2.0% yield obtained if we add NADPH exogenously (Fig. 6b). If we leave out any of the purge valve components (PDHNADPH, PDHNADH or NoxE), yields are markedly reduced. Thus, the purge valve system is clearly transportable to other synthetic biochemistry systems.DiscussionMaintaining proper cofactor balance is an essential part of generating flux and providing a driving force through an enzymatic pathway. In vivo, the enzymatic specificity for the cofactors NADH and NADPH are typically used to control the carbon flux through catabolic and anabolic pathways, respectively. Organisms typically sense the reduction state of these cofactors and use this information to upregulate or downregulate catabolic and anabolic pathways to cope with environmental changes. In vitro systems, however, do not have the myriad peripheral pathways that facilitate this fine control. Moreover, the natural anabolic and catabolic specificities for NADH and NADPH complicate in vitro biotransformations. Synthetic biochemistry systems have often dealt with these problems by careful considerations of cofactor stoichiometry in pathway design, through the use of expensive sacrificial metabolites, re-engineering enzymes so that only a single cofactor type is needed, adding excess cofactors, or constantly adding intermediates to the reaction mix to sustain the process.In this work, we created a robust node of control to balance the production and consumption of NADPH and NADH in a self-regulating and self-balancing manner. To our knowledge, this is the first in vitro pathway that maintains cofactor balance without requiring adherence to stoichiometry in the generation and utilization of cofactors to ensure carbon flux. In part because the system can sustain high levels of NADPH, we can drive the transformation to near completion, converting pyruvate to either PHB or isoprene at nearly 100% of the theoretical yield. Moreover, the high yields in our system are robust to 10-fold variations in cofactor levels.Ultimately it will be necessary to expand this pathway to incorporate the conversion of low-cost substrates such as glucose or other sugars into pyruvate, which would involve the glycolysis pathway or parts of the glycolysis pathway. Indeed a synthetic biochemistry system employing glycolysis has been demonstrated previously5. Building more complex compounds from acetyl-CoA such as fatty acids, polyketides and other isoprenoids will also require the incorporation and recycling of ATP. Thus, it would be desirable to develop simple methods to regulate the ATP/ADP levels within the context of synthetic biochemistry. ATP regulation will be an interesting challenge for future synthetic biochemistry pathway designs. Ultimately, developing regulatory systems similar to the purge valve employed here will free synthetic biochemistry system design from having to consume the high-energy cofactors during the anabolic phase in perfect stoichiometric balance. Thus, our approach can help diversify the chemical targets of synthetic biochemistry.MethodsMaterialsMiller Luria-Bertani (LB) media or Miller LB-agar (BD Difco) was used for growth of bacterial strains in liquid or solid media. E. coli BL21-Gold(DE3) (B, F-, ompT, hsdSB, (rB鈭?mB鈭?, dcm+,Tetr,gal位, (DE3) endA Hte) (Agilent) was used as a host for both cloning and expression of recombinant proteins using pET vectors. E. coli TOP10(DE3) (F- mcrA 螖(mrr-hsdRMS-mcrBC) 蠁80lacZ螖M15 螖lacX74 nupG recA1 araD139 螖(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 位鈭?/sup>) was used for expression of recombinant proteins from the pBAD/p15A vector37. Plasmids pET28a(+) and pET22b(+) were purchased from Novagen. HotStart Taq Mastermix (Denville) was used for gene amplification from genomic or plasmid DNA. Phusion DNA polymerase (Finnizymes), Taq DNA ligase (MCLab), and T5 Exonuclease (Epicenter) were purchased separately and used to make the assembly master mix (AMM) used for cloning (ref). ATP, (卤)-伪-lipoic acid, pyruvate, coenzyme A and NAD+ were from Sigma.Plasmid constructionThe expression plasmids for the PHB enzymes were constructed from the pET28a plasmid backbone using the Nde1- and Sac1-cut sites to produce constructs with an N-terminal 6 脳 His tag for purification. The genes encoding acetyl-CoA acetyltraferase (phaA; YP_725941) and acetoacetyl-CoA reductase (phaB; YP_725942)23 were amplified and cloned from Ralstonia eutropha genomic DNA. The gene encoding PHB synthase38,39 (phaC; HE_610111) was synthesized and codon optimized for expression in an E. coli host at Life Technologies before being subcloned into the pET28a expression vector. For the isoprene pathway, the constructs were the same as described in reference30.E. coli BL21-Gold cells were used as the host strain for enzyme expression. All enzymes were expressed in LB media supplemented with 50鈥壩糶鈥塵l鈭? kanamycin and were induced with 0.2鈥塵M isopropyl-尾-D-1-thiogalactopyranoside added to the culture at the end of log phase growth. The phaA, phaB, MVK, PMVK and IspS were induced at 37鈥壜癈 overnight and phaB, THL/HMGR, HMGS and IDI were induced at 18鈥壜癈 overnight. The phaC was induced at 25鈥壜癈 for 5鈥塰 before harvesting.Enzyme purificationCells from 0.5鈥塴 of culture were harvested by centrifugation and resuspended in 150鈥塵M Tris pH 7.5, 100鈥塵M NaCl. The cells were lysed on ice with sonication and the cell debris was removed by 12,000鈥?i>g centrifugation at 4鈥壜癈. The supernatant was then mixed with 5鈥塵l nickel-nitrilotriacetic acid agarose and after 30鈥塵in, the agarose slurry was loaded onto a gravity column and washed with five-column volumes of 100鈥塵M Tris pH 7.5, 100鈥塵M NaCl and 15鈥塵M imidazole. The enzyme was then eluted with 250鈥塵M imidazole, 100鈥塵M Tris pH 7.5. The resulting enzyme was dialysed into 50鈥塵M Tris pH 7.5, 50鈥塵M NaCl and stored at 4鈥壜癈.Expression vectors for PDH subunits and E. coli LplAThe E1, E2 and E3 domains were all amplified separately from G. stearothermophilus genomic DNA (ATCC) using primers that contained 15鈥?0鈥塨p complementary to the gene and 15鈥?0鈥塨p complementary to the multiple cloning site in the vector where the gene would be placed. The genes encoding E1伪 and E1尾 were amplified together from G. stearothermophilus genomic DNA and cloned into pET28a(+) that had been digested with NcoI and XhoI. This created a tagless construct for E1 expression under control of the T7 promoter where E1伪 translation uses the ribosomal binding site from the pET28 vector while E1尾 uses the endogenous ribosomal binding site from G. stearothermophilus. The E2 and E3 domains were amplified separately and cloned into pET22b(+) digested with NdeI and XhoI or pET28a(+) digested with NcoI and XhoI, respectively, to create tagless E2 and E3 constructs. The E. coli lipoate protein ligase, LplA, was amplified from E. coli K12 genomic DNA and assembled into pBAD/p15A37 digested with XhoI and EcoRI to create 6 脳 His-LplA.Overexpression and purification of PDH subunits and LplAAll E. coli strains were grown at 37鈥壜癈 in LB-media supplemented with appropriate antibiotic (100鈥壩糶鈥塵l鈭? ampicillin, 50鈥壩糶鈥塵l鈭? kanamycin or 34鈥壩糶鈥塵l鈭? chloramphenicol). For all constructs, 5鈥塵l of overnight starter culture was used to inoculate 1鈥塴 of LB-media. Once the OD600 reached 0.6, 0.3鈥塵M IPTG (pET vectors) or 0.02% arabinose (pBAD/p15A) was added to induce protein expression. After 16鈥塰, cells were harvested, resuspended (4鈥塵l鈥塯鈭? wet cells) in 50鈥塵M Tris-Cl pH 7.5, 0.1鈥塎 NaCl (buffer A), lysed by sonication and cell debris removed by centrifugation at 30,000鈥?i>g for 20鈥塵in.E. coli lysate (25鈥塵l) containing 6 脳 His-LplA was loaded onto a 3-ml nickel-nitrilotriacetic acid resin (Qiagen), washed with 25鈥塵l buffer A containing 10鈥塵M imidazole and eluted with 5鈥塵l buffer A containing 250鈥塵M imidazole. Pure 6 脳 His-LplA was then stored at 4鈥壜癈 until use.The individual domains of G. stearothermophilus PDH were partially purified from E. coli lysates by heat before modification and reconstitution of the PDH complex. E1伪尾-, E2- or E3-containing lysates were incubated at 65鈥壜癈 for 35鈥塵in to heat denature E. coli proteins followed by centrifugation at 30,000g for 20鈥塵in to pellet the precipitated proteins. Nearly all of the PDH domains remain in the supernatant. Next, the E2 domain was lipoated in the heated extract by the addition of 1鈥塵M (卤)-伪-lipoic acid, 2鈥塵M ATP, 3鈥塵M MgCl2 and 50鈥壩糶 of purified 6 脳 His-LplA. The lipoation reaction was then allowed to proceed with gentle mixing overnight at 25鈥壜癈, yielding lipoated E2 (E2lip). After lipoation, E1伪尾, E2lip and E3 were mixed in a 3:1:3 molar ratio and incubated for at least 1鈥塰 at 25鈥壜癈 to form the active GsPDH complex. The GsPDH complex was then isolated by ultracentrifugation (Beckman) for 4鈥塰 at 95,000鈥?i>g. The resulting yellow pellet was resuspended in 20鈥塵M Tris-Cl, pH 7.5 in 1/50 the starting volume and assayed for activity33,34,40. SDS鈥損olyacrylamide gel electrophoresis analysis confirmed the presence of all four domains and indicated that the preparation was 90% pure. The reconstituted complex was stored at 4鈥壜癈 until use.Enzyme activity and optimizationNoxE was assayed by monitoring the oxidation of NAD(P)H at 340鈥塶m. The assay was carried out in 100鈥塵M Tris鈥揌Cl pH 7.5, 5鈥塵M MgCl2, 5鈥塵M KCl and 0.2鈥塵M NAD(P)H.WT and mutant PDH were assayed by monitoring the reduction of NAD(P)+ at 340鈥塶m. The assay was carried out in 50鈥塵M Tris pH 7.5, 5鈥塵M MgCl2, 5鈥塵M pyruvate, 1鈥塵M CoA and 0.5鈥塵M of NAD(P)+.PhaC was assayed by monitoring the absorbance of the hydrolysis of the thioester bond of the substrate 3HBCoA at 235鈥塶m. The assay was carried out in 100鈥塵M Tris pH 7.5, 5鈥塵M MgCl2 and 0.15鈥塵M 3HBCoA.Activity of NADPH-consuming isoprene pathway enzymes were monitored with the decrease of absorbance at 340鈥塶m. Activity of ATP-consuming enzymes were monitored with a coupled assay system with pyruvate kinase and lactate dehydrogenase at 340鈥塶m. The amount of each enzyme in the reconstituted isoprene pathway described below is show in Supplementary Table 2.Final PHB reaction conditions and analysisThe optimized self-sustaining reaction for the biotransformation of pyruvate to PHB was composed of 250鈥塵M Tris pH 7.5, 5鈥塵M MgCl, 5鈥塵M KCl, 0.5鈥塵M CoA, 0.1鈥塵M NAD+, 0.5鈥塵M NADP+, 50鈥塵M pyruvate, 2鈥壩糶 PDHNADH, 76鈥壩糶 PDHNADPH, 23鈥壩糶 phaA, 14 渭gphaB and 32鈥壩糶 phaC in a final reaction volume of 200鈥壩糽. The reactions were initiated with the addition of pyruvate, which was left out of the initial mixture. All PHB reactions were performed at room temperature. For testing the autoregulatory behaviour of the purge valve, some enzyme concentrations were sub-optimal: 5鈥壩糶 phaA, 2.5鈥壩糶 phaB and 1.9鈥壩糶 phaC.To assay for PHB, the reactions were lyophilized and incubated with 1鈥塵l chloroform, 0.45鈥塵l methanol and 0.05鈥塵l H2SO4 to hydrolyse the polymer and generate methyl 3-hydroxybutyrate. The reactions were extracted with 0.5鈥塵l water and 1鈥壩糽 of the chloroform layer was applied to a 0.25-micron HP-Innowax column using a HP 5890 Series II gas chromatogram. The gas chromatography method used an injection temperature that was held at 35鈥壜癈 for 5鈥塵in before it was increased to 275鈥壜癈 over 40鈥塵in. The peak intensities were compared with an authentic standard to assess concentrations.Isoprene reaction conditions and analysisIn vitro production of isoprene was performed as described previously30 with the following changes. 200鈥壩糽 reactions were set up in 2-ml gas-tight vials containing enzymes, 3鈥塵M pyruvate, 15鈥塵M ATP, 0.6鈥塵M CoA, 0.2鈥塵M NAD+, 0.4鈥塵M NADP+ (or 5鈥塵M NADPH), 10鈥塵M MgCl2, 20鈥塵M KCl and 0.1鈥塵M thiamine pyrophosphate in 100鈥塵M Tris-Cl pH 8.5 and incubated at 32鈥壜癈 for 18鈥塰. Isoprene production was monitored by direct sampling of 100鈥壩糽 of the headspace using a 100-渭l gas-tight syringe. The headspace was analysed by GC-FID (HP5980II) equipped with a GS-GasPro column (0.32鈥塵m 脳 30鈥塵, Agilent) as described previously30. The carrier gas was helium with a flow rate of 5鈥塵l鈥塵in鈭?. The oven temperature was kept at 120鈥壜癈 for 3鈥塵in then raised to 230鈥壜癈 at 5鈥塁鈥塵in鈭? then to 250鈥壜癈 at 20鈥壜癈鈥塵in鈭? and held for at 250鈥壜癈 for 9鈥塵in. The inlet and detector temperatures were kept at 270 and 330鈥壜癈, respectively. The amount of isoprene produced was quantified by comparison with a standard curve of various isoprene concentrations sampled in the same manner.Additional informationHow to cite this article: Opgenorth, P. H. et al. A synthetic biochemistry molecular purge valve module that maintains redox balance. Nat. Commun. 5:4113 doi: 10.1038/ncomms5113 (2014). References1Zhang, Y. H. P. Simpler is better: high-yield and potential low-cost biofuels production through cell-free synthetic pathway biotransformation (SyPaB). ACS Catal. 1, 998鈥?009 (2011).CAS聽 Article聽Google Scholar聽 2Hold, C. Panke, S. Towards the engineering of in vitro systems. J. R. Soc. Interface 6, (Suppl 4)S507鈥揝521 (2009).CAS聽 Article聽Google Scholar聽 3Rollin, J. A., Tam, T. K. Zhang, Y. H. P. New biotechnology paradigm: cell-free biosystems for biomanufacturing. Green Chem. 15, 1708鈥?719 (2013).CAS聽 Article聽Google Scholar聽 4Algar, E. M. Scopes, R. K. Studies on cell-free metabolism鈥攅thanol-production by extracts of zymomonas-mobilis. J. Biotechnol. 2, 275鈥?87 (1985).CAS聽 Article聽Google Scholar聽 5Welch, P. Scopes, R. K. Studies on cell-free metabolism鈥攅thanol-production by a yeast glycolytic system reconstituted from purified enzymes. J. Biotechnol. 2, 257鈥?73 (1985).CAS聽 Article聽Google Scholar聽 6Bujara, M., Schumperli, M., Billerbeek, S., Heinemann, M. Panke, S. Exploiting cell-free systems: implementation and debugging of a system of biotransformations. Biotechnol. Bioeng. 106, 376鈥?89 (2010).CAS聽 PubMed聽Google Scholar聽 7Bujara, M., Schumperli, M., Pellaux, R., Heinemann, M. Panke, S. Optimization of a blueprint for in vitro glycolysis by metabolic real-time analysis. Nat. Chem. Biol. 7, 271鈥?77 (2011).CAS聽 Article聽Google Scholar聽 8Ye, X. et al. Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway. Microb. Cell. Fact. 11, 120 (2012).CAS聽 Article聽Google Scholar聽 9Ye, X., Honda, K., Morimoto, Y., Okano, K. Ohtake, H. Direct conversion of glucose to malate by synthetic metabolic engineering. J. Biotechnol. 164, 34鈥?0 (2013).CAS聽 Article聽Google Scholar聽 10Yu, X. Y., Liu, T. G., Zhu, F. Y. Khosla, C. In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli. Proc. Natl Acad. Sci. USA 108, 18643鈥?8648 (2011).CAS聽 ADS聽 Article聽Google Scholar聽 11Jewett, M. C. Swartz, J. R. Rapid expression and purification of 100 nmol quantities of active protein using cell-free protein synthesis. Biotechnol. Prog. 20, 102鈥?09 (2004).CAS聽 Article聽Google Scholar聽 12Jewett, M. C., Calhoun, K. A., Voloshin, A., Wuu, J. J. Swartz, J. R. An integrated cell-free metabolic platform for protein production and synthetic biology. Mol. Syst. Biol. 4, 220 (2008).Article聽Google Scholar聽 13Schultheisz, H. L., Szymczyna, B. R., Scott, L. G. Williamson, J. R. Pathway engineered enzymatic de novo purine nucleotide synthesis. ACS Chem. Biol. 3, 499鈥?11 (2008).CAS聽 Article聽Google Scholar聽 14Schultheisz, H. L., Szymczyna, B. R., Scott, L. G. Williamson, J. R. Enzymatic de novo pyrimidine nucleotide synthesis. J. Am. Chem. Soc. 133, 297鈥?04 (2011).CAS聽 Article聽Google Scholar聽 15Zhang, Y. H. P., Evans, B. R., Mielenz, J. R., Hopkins, R. C. Adams, M. W. W. High-yield hydrogen production from starch and water by a synthetic enzymatic pathway. PLoS ONE 2, e456 (2007).ADS聽 Article聽Google Scholar聽 16Ye, X. H. et al. Spontaneous high-yield production of hydrogen from cellulosic materials and water catalyzed by enzyme cocktails. ChemSusChem 2, 149鈥?52 (2009).CAS聽 Article聽Google Scholar聽 17Woodward, J., Orr, M., Cordray, K. Greenbaum, E. Biotechnology鈥攅nzymatic production of biohydrogen. Nature 405, 1014鈥?015 (2000).CAS聽 ADS聽 Article聽Google Scholar聽 18Krutsakorn, B. et al. In vitro production of n-butanol from glucose. Metab. Eng. 20, 84鈥?1 (2013).CAS聽 Article聽Google Scholar聽 19Guterl, J. K. et al. Cell-free metabolic engineering: production of chemicals by minimized reaction cascades. ChemSusChem 5, 2165鈥?172 (2012).CAS聽 Article聽Google Scholar聽 20Chen, G.-Q. inPlastics from Bacteria: Natural Functions and Applications Vol. 14 Microbiology Monographs ed Chen G. Q. 121鈥?32Springer (2010).21Kawada, J., Lutke-Eversloh, T., Steinbuchel, A. Marchessault, R. H. Physical properties of microbial polythioesters: characterization of poly(3-mercaptoalkanoates) synthesized by engineered Escherichia coli. Biomacromolecules 4, 1698鈥?702 (2003).CAS聽 Article聽Google Scholar聽 22Dawes, E. A. Polyhydroxybutyrate鈥攁n intriguing bio-polymer. Biosci. Rep. 8, 537鈥?47 (1988).CAS聽 Article聽Google Scholar聽 23Satoh, Y., Tajima, K., Tannai, H. Munekata, M. Enzyme-catalyzed poly(3-hydroxybutyrate) synthesis from acetate with CoA recycling and NADPH regeneration in vitro. J. Biosci. Bioeng. 95, 335鈥?41 (2003).CAS聽 Article聽Google Scholar聽 24Yang, J. et al. Enhancing production of bio-isoprene using hybrid MVA pathway and isoprene synthase in E. coli. PLoS ONE 7, e33509 (2012).CAS聽 ADS聽 Article聽Google Scholar聽 25Kesselmeier, J. Staudt, M. Biogenic volatile organic compounds (VOC): an overview on emission, physiology and ecology. J. Atmos. Chem. 33, 23鈥?8 (1999).CAS聽 Article聽Google Scholar聽 26Lindberg, P., Park, S. Melis, A. Engineering a platform for photosynthetic isoprene production in cyanobacteria, using Synechocystis as the model organism. Metab. Eng. 12, 70鈥?9 (2010).CAS聽 Article聽Google Scholar聽 27Peralta-Yahya, P. P., Zhang, F. Z., del Cardayre, S. B. Keasling, J. D. Microbial engineering for the production of advanced biofuels. Nature 488, 320鈥?28 (2012).CAS聽 ADS聽 Article聽Google Scholar聽 28Yang, J. M. et al. Bio-isoprene production using exogenous MVA pathway and isoprene synthase in Escherichia coli. Bioresour. Technol. 104, 642鈥?47 (2012).CAS聽 Article聽Google Scholar聽 29Xue, J. Ahring, B. K. Enhancing isoprene production by genetic modification of the 1-deoxy-D-xylulose-5-phosphate pathway in Bacillus subtilis. Appl. Environ. Microbiol. 77, 2399鈥?405 (2011).CAS聽 Article聽Google Scholar聽 30Korman, T. P. et al. A synthetic biochemistry system for the in vitro production of isoprene from glycolysis intermediates. Protein Sci. 23, 576鈥?85 (2014).CAS聽 Article聽Google Scholar聽 31Kawasaki, S., Ishikura, J., Chiba, D., Nishino, T. Niimura, Y. Purification and characterization of an H2O-forming NADH oxidase from Clostridium aminovalericum: existence of an oxygen-detoxifying enzyme in an obligate anaerobic bacteria. Arch. Microbiol. 181, 324鈥?30 (2004).CAS聽 Article聽Google Scholar聽 32Geueke, B., Riebel, B. Hummel, W. NADH oxidase from Lactobacillus brevis: a new catalyst for the regeneration of NAD. Enzyme Microb. Technol. 32, 205鈥?11 (2003).CAS聽 Article聽Google Scholar聽 33Bocanegra, J. A., Scrutton, N. S. Perham, R. N. Creation of an nadp-dependent pyruvate-dehydrogenase multienzyme complex by protein engineering. Biochemistry 32, 2737鈥?740 (1993).CAS聽 Article聽Google Scholar聽 34Richter, N., Zienert, A. Hummel, W. A single-point mutation enables lactate dehydrogenase from Bacillus subtilis to utilize NAD(+) and NADP(+) as cofactor. Eng. Life Sci. 11, 26鈥?6 (2011).CAS聽 Article聽Google Scholar聽 35Gao, H., Tiwari, M. K., Kang, Y. C. Lee, J. K. Characterization of H2O-forming NADH oxidase from Streptococcus pyogenes and its application in L-rare sugar production. Bioorg. Med. Chem. Lett. 22, 1931鈥?935 (2012).CAS聽 Article聽Google Scholar聽 36Gerngross, T. Martin, D. Enzyme-catalyzed synthesis of poly [(R)-(-)-3-hydroxybutyrate]: formation of macroscopic granules in vitro. Proc. Natl Acad. Sci. USA 92, 6279鈥?283 (1995).CAS聽 ADS聽 Article聽Google Scholar聽 37Massey-Gendel, E. et al. Genetic selection system for improving recombinant membrane protein expression in E-coli. Protein Sci. 18, 372鈥?83 (2009).CAS聽 Article聽Google Scholar聽 38Rehm, B. H. A. Polyester synthases: natural catalysts for plastics. Biochem. J. 376, 15鈥?3 (2003).CAS聽 Article聽Google Scholar聽 39Sheu, D. S., Chen, W. M., Lai, Y. W. Chang, R. C. Mutations derived from the thermophilic polyhydroxyalkanoate synthase PhaC enhance the thermo stability and activity of PhaC from Cupriavidus necator H16. J. Bacteriol. 194, 2620鈥?629 (2012).CAS聽 Article聽Google Scholar聽 40Kim, D. J. et al. Crystal structure of lipoate-protein ligase A bound with the activated intermediate鈥擨nsights into interaction with lipoyl domains. J. Biol. Chem. 280, 38081鈥?8089 (2005).CAS聽 Article聽Google Scholar聽 Download referencesAcknowledgementsWe thank members of the Bowie lab for critical reading of this manuscript. The work was supported by the DOE grant DE-FC02-02ER63421 to J.U.B.Author informationAffiliationsDepartment of Chemistry and Biochemistry, UCLA-DOE Institute for Genomics and Proteomics, Molecular Biology Institute, University of California, Los Angeles, 90095-1570, California, USAPaul H. Opgenorth,聽Tyler P. Korman聽 聽James U. BowieBoyer Hall, UCLA, 611 Charles E Young Drive East, Los Angeles, 90095-1570, California, USAJames U. BowieAuthorsPaul H. OpgenorthView author publicationsYou can also search for this author in PubMed聽Google ScholarTyler P. KormanView author publicationsYou can also search for this author in PubMed聽Google ScholarJames U. BowieView author publicationsYou can also search for this author in PubMed聽Google ScholarContributionsP.H.O., T.P.K. and J.U.B. designed the experiments, analysed experimental results and wrote the maunscript. P.H.O. and T.P.K. conducted the experiments.Corresponding authorCorrespondence to James U. Bowie.Ethics declarations Competing interests The authors declare no competing financial interests. Supplementary information Supplementary InformationSupplementary Figures 1-2, Supplementary Tables 1-4 and Supplementary References (PDF 423 kb)Rights and permissionsReprints and PermissionsAbout this articleCite this articleOpgenorth, P., Korman, T. Bowie, J. A synthetic biochemistry molecular purge valve module that maintains redox balance. Nat Commun 5, 4113 (2014). https://doi.org/10.1038/ncomms5113Download citationReceived: 19 December 2013Accepted: 14 May 2014Published: 17 June 2014DOI: https://doi.org/10.1038/ncomms5113 Saken Sherkhanov, Tyler P. Korman, Sum Chan, Salem Faham, Hongjiang Liu, Michael R. Sawaya, Wan-Ting Hsu, Ellee Vikram, Tiffany Cheng James U. Bowie Nature Communications (2020) Simon Burgener, Shanshan Luo, Richard McLean, Tarryn E. Miller Tobias J. Erb Nature Catalysis (2020) Meaghan A. Valliere, Tyler P. Korman, Nicholas B. Woodall, Gregory A. Khitrov, Robert E. Taylor, David Baker James U. Bowie Nature Communications (2019) Thomas Beneyton, Dorothee Krafft, Claudia Bednarz, Christin Kleineberg, Christian Woelfer, Ivan Ivanov, Tanja Vidakovi膰-Koch, Kai Sundmacher Jean-Christophe Baret Nature Communications (2018) CommentsBy submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Sign up for the Nature Briefing newsletter 鈥?what matters in science, free to your inbox daily.